학술논문

Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial
Document Type
Article
Source
In: Vaccine. (Vaccine, 2 April 2024, 42(9):2290-2298)
Subject
Language
English
ISSN
18732518
0264410X